IRCT2012091510841N1
Completed
Phase 2
Clinical effects of inhalational nitrous oxide 50% on childbirth anxiety in cesarean section under spinal anesthesia
Hamadan University Of Medical Science, Vice chancellor for research0 sites56 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Childbirth Anxiety under spinal anesthesia.
- Sponsor
- Hamadan University Of Medical Science, Vice chancellor for research
- Enrollment
- 56
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •primigravid patients; 18\-45 years old; educated; scheduled for cesarean section under spinal anesthesia. Exclusion criteria: Pre\-eclampsia \& Eclampsia; Vavular Heart Disease; Respiratory Disease; Previous Nausea \&Vomiting Ear Disease or Surgery; Increased ICP; Anemia; Shock; Patient refusal.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Effect of nitrous oxide inhalation sedation on childs anxiety and parental opinion during dental proceduresCTRI/2024/06/068490ANIL NEERUKONDA INSTITUTE OF DENTAL SCIENCES
Completed
Not Applicable
Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella).JPRN-UMIN000050133Iwate Medical University50
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD)Implantation. - INOT41acute right ventricular failureMedDRA version: 9.1Level: LLTClassification code 10063082Term: Acute right ventricular failureEUCTR2005-000326-24-DEINO Therapeutics110
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD) Implantation. - INOT41EUCTR2005-000326-24-GBINO Therapeutics110
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0 Level: LLT Classification code 10054933EUCTR2004-002312-29-GBINO Therapeutics800